CIK 0000873303
- Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 930797222
- Phone
- +1 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-10-31 | BEHRENS M KATHLEEN Director | Exercise or conversion | +10,000 | $3.96 | $40K | 126,534 |
| 2018-10-31 | BEHRENS M KATHLEEN Director | Sale | −10,000 | $131.71 | $1.3M | 116,534 |
| 2018-10-31 | BEHRENS M KATHLEEN Director | Exercise or conversion · Stock Option (right to buy) | −10,000 | 0 | ||
| 2018-10-30 | INGRAM DOUGLAS S President & CEO | Purchase | +13,561 | $120.26 | $1.6M | 412,811 |
| 2018-10-30 | INGRAM DOUGLAS S President & CEO | Purchase | +3,134 | $120.94 | $379K | 415,945 |
| 2018-10-24 | Mahatme Sandesh EVP, CFO & CBO | Exercise or conversion | +9,596 | $23.85 | $229K | 48,381 |
| 2018-10-24 | Mahatme Sandesh EVP, CFO & CBO | Exercise or conversion | +39,006 | $13.90 | $542K | 87,387 |
| 2018-10-24 | Mahatme Sandesh EVP, CFO & CBO | Exercise or conversion | +29,080 | $13.71 | $399K | 116,467 |
| 2018-10-24 | Mahatme Sandesh EVP, CFO & CBO | Exercise or conversion | +11,718 | $13.71 | $161K | 128,185 |
| 2018-10-24 | Mahatme Sandesh EVP, CFO & CBO | Sale | −107,524 | $127.74 | $13.7M | 20,661 |
| 2018-10-24 | Mahatme Sandesh EVP, CFO & CBO | Gift | −12,012 | 8,649 | ||
| 2018-10-24 | Mahatme Sandesh EVP, CFO & CBO | Gift | +12,012 | 12,012 | ||
| 2018-10-24 | Mahatme Sandesh EVP, CFO & CBO | Exercise or conversion · Stock Option (right to buy) | −9,596 | 116,009 | ||
| 2018-10-24 | Mahatme Sandesh EVP, CFO & CBO | Exercise or conversion · Stock Option (right to buy) | −39,006 | 17,860 | ||
| 2018-10-24 | Mahatme Sandesh EVP, CFO & CBO | Exercise or conversion · Stock Option (right to buy) | −29,080 | 7,899 | ||
| 2018-10-24 | Mahatme Sandesh EVP, CFO & CBO | Exercise or conversion · Stock Option (right to buy) | −11,718 | 12,873 | ||
| 2018-08-15 | INGRAM DOUGLAS S President & CEO | Purchase | +16,000 | $125.26 | $2.0M | 399,250 |
| 2018-08-08 | Cumbo Alexander SVP, Chief Commercial Officer | Shares withheld for taxes | −6,000 | $121.02 | $726K | 22,766 |
| 2018-08-08 | Howton David T SVP, General Counsel | Shares withheld for taxes | −6,800 | $121.02 | $823K | 28,071 |
| 2018-08-08 | Mahatme Sandesh EVP, CFO & CBO | Shares withheld for taxes | −8,501 | $121.02 | $1.0M | 38,785 |
Page 33 of 38 · 760 trades